You are here

  • Home
  • Online First
  • Robotic fertility-sparing surgery for early-stage epithelial ovarian cancer

Article Text

Article menu

other Versions

Download PDFPDF

Video article
Robotic fertility-sparing surgery for early-stage epithelial ovarian cancer
Free
  1. Henri Azais1,2,
  2. Meriem Koual1,2,
  3. Huyên-Thu Nguyen-Xuan1,
  4. Guillaume Achen1,2,
  5. Enrica Bentivegna1 and
  6. Anne-Sophie Bats1,2
  1. 1Gynecologic and Breast Oncologic Surgery, Hôpital Européen Georges-Pompidou, Paris, Île-de-France, France
  2. 2Faculté de Médecine Paris-Descartes, Université de Paris, Paris, Île-de-France, France
  1. Correspondence to Dr Henri Azais, Gynecologic and Breast Oncologic Surgery, Hôpital Européen Georges-Pompidou Service de Chirurgie Cancérologique Gynécologique et du Sein, 75015 Paris, Île-de-France, France; henri.azais{at}aphp.fr

https://doi.org/10.1136/ijgc-2021-002799

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The objective of the video article is to present a complete robotic restaging surgery for an early stage endometrioid ovarian cancer developed in an endometrioma in a young patient wishing to preserve her fertility. We demonstrate the entire surgical technique of restaging. Institutional review board approval was not required for this video presentation.

    We present the case of a 27-year-old patient with one child and no medical history who was treated in emergency for a right adnexal torsion by laparoscopy. A cystectomy was performed with perioperative rupture of the cyst. The analysis of the surgical specimen led to the diagnosis of grade 1 endometrioid ovarian cancer developed within an endometrioma.

    The patient underwent a complete surgical staging including pelvic and para-aortic lymph node dissections, appendectomy, omentectomy and right salpingo-oophorectomy by robot-assisted laparoscopy.

    All specimens were negative at final pathology examination and the disease was confirmed at stage 1C1 (peroperative spillage). There were no surgical complications. No adjuvant treatment was indicated. The patient was pregnant 2 months after the surgery.

    Fertility-sparing minimally invasive surgery is acceptable for women of childbearing age who want to become pregnant in the case of early-stage ovarian cancer, after adequate staging. Minimally invasive surgery is safe,1 effective, and particularly adapted for women who wish to preserve their fertility without compromising oncological outcomes. This option may be safely proposed for 1A and 1C1, low-grade serous or endometrioid ovarian cancer.2 3 Complete information about oncological and obstetrical outcomes is mandatory and patients should agree to comply with close follow-up.4

    In conclusion, minimally invasive fertility-sparing surgery is safe and effective for women with early-stage ovarian cancer.

    Video 1
    Figure 1
    Figure 1

    Anatomical variation (latero-aortic left renal vein) during robotic assisted para-aortic lymph node dissection for restaging of an early-stage ovarian cancer.

    Data availability statement

    There are no data in this work.

    Ethics statements

    References

    1. ↵
      1. Merlier M,
      2. Kerbage Y,
      3. Pierache A, et al
      . Impact on prognosis of the surgical route, laparoscopy or laparotomy, for the surgical staging of early stage ovarian cancer-a study from the FRANCOGYN group. J Clin Med 2020;9. doi:doi:10.3390/jcm9113528. [Epub ahead of print: 31 Oct 2020].pmid:http://www.ncbi.nlm.nih.gov/pubmed/33142772
      OpenUrlPubMed
    2. ↵
      1. Bentivegna E,
      2. Fruscio R,
      3. Roussin S, et al
      . Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients. Fertil Steril 2015;104:1319–24.doi:10.1016/j.fertnstert.2015.06.008pmid:http://www.ncbi.nlm.nih.gov/pubmed/26149354
      OpenUrlCrossRefPubMed
    3. ↵
      1. Bentivegna E,
      2. Morice P,
      3. Uzan C, et al
      . Fertility-sparing surgery in epithelial ovarian cancer. Future Oncol 2016;12:389–98.doi:10.2217/fon.15.319pmid:http://www.ncbi.nlm.nih.gov/pubmed/26768952
      OpenUrlCrossRefPubMed
    4. ↵
      1. Bentivegna E,
      2. Gouy S,
      3. Maulard A, et al
      . Fertility-sparing surgery in epithelial ovarian cancer: a systematic review of oncological issues. Ann Oncol 2016;27:1994–2004.doi:10.1093/annonc/mdw311pmid:http://www.ncbi.nlm.nih.gov/pubmed/27502723
      OpenUrlCrossRefPubMed

    Footnotes

    • Twitter @Henriaz

    • Contributors Conception and design of study: HA, MK, A-SB. Data collection: HA, EB, MK. Data analysis and interpretation: HA, MK, H-TN-X, EB. Responsible surgeon or imager: HA, EB, GA. Manuscript preparation: HA, MK, EB. Patient recruitment: HA, A-SB.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.